Novitium Pharma's ANDA078083 for Glipizide and Metformin Hydrochloride Approved
The FDA has approved Novitium Pharma's Abbreviated New Drug Application (ANDA078083) for Glipizide and Metformin Hydrochloride.
Asset / Drug
Drug and asset intelligence for Glipizide with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.